Management of Hereditary Breast Cancer: ASCO, ASTRO and SSO Guideline – April 2020
Date: April 3, 2020
SSO collaborated with the American Society of Clinical Oncology and the American Society for Radiation Oncology to develop, Management of Hereditary Breast Cancer: ASCO, ASTRO and SSO Guideline. The multidisciplinary, expert panel addressed 10 clinical practice questions in the guideline. Recommendations were developed using the ASCO modified Delphi formal consensus methodology. In addition to SSO participation in the Expert Panel, the Guideline was reviewed by members of SSO’s Breast Disease Site Work Group, the Chair of the SSO Quality Committee and approved by the SSO Executive Council.
In addition, SSO’s Breast Disease Site Work Group Chair and Vice Chair published the following Editorial on the Guideline. McGuire KP, Mamounas EP. Management of hereditary breast cancer: ASCO, ASTRO, and SSO Guideline. Ann Surg Oncol. 2020. https:doi.org/10.1245/s10434-020-08396-8. The editorial comments on various aspects of the Guideline including surgical management, radiation therapy and systemic therapy.